DS
REVH

David Shaw’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

David Shaw’s Portfolio REVH Stock Details REVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-390,687
Closed -$3.84M – 5473
2022
Q3 		$3.84M Hold
390,687
– – ﹤0.01% 2376
2022
Q2 		$3.81M Hold
390,687
– – ﹤0.01% 2463
2022
Q1 		$3.83M Sell
390,687
-443,023
-53% -$4.31M ﹤0.01% 2627
2021
Q4 		$8.1M Buy
833,710
+694,079
+497% +$6.78M 0.01% 1878
2021
Q3 		$1.36M Buy
139,631
+84,324
+152% +$821K ﹤0.01% 3363
2021
Q2 		$543K Buy
+55,307
New +$545K ﹤0.01% 4000

David Shaw's REVH Position: Q4 2022 in Review

David Shaw sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 390,687 shares — an estimated $3.84M sold.

David Shaw first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $8.1M in Q4 2021. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

  • David Shaw reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 390,687 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $3.84M.
  • David Shaw first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • David Shaw's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $8.1M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.